Discover more insights into Triple Antithrombotic 삼중 항혈전제

Keywords frequently search together with Triple Antithrombotic 삼중 항혈전제

Narrow sentence examples with built-in keyword filters

Triple Antithrombotic sentence examples within dual antiplatelet therapy



Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.


Impact of Platelet Reactivity in ACS Patients on Clinical Outcomes with Triple Antithrombotic Therapy

Triple Antithrombotic sentence examples within acute coronary syndrome



Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation – Balancing Risks and Benefits


Uneventful epidural catheter removal in a patient with postoperative acute coronary syndrome receiving emergency triple antithrombotic therapy: a case report.

Triple Antithrombotic sentence examples within undergoing percutaneous coronary



Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines-data from the POLish Atrial Fibrillation (POL-AF) Registry.


Triple Antithrombotic Therapy vs. Double Antithrombotic Therapy: One Scenario, 8 Questions, Many Conclusions


Learn more from Triple Antithrombotic 삼중 항혈전제


Triple Antithrombotic sentence examples within percutaneous coronary intervention



Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation


Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse events

Triple Antithrombotic sentence examples within dual antithrombotic therapy



Antithrombotic strategy in patients with atrial fibrillation and acute coronary syndrome


One-year clinical outcome of patients with left ventricular thrombus after acute myocardial infarction discharged on triple or dual antithrombotic therapy

Triple Antithrombotic sentence examples within Versu Triple Antithrombotic



Antithrombotic regimen for patients with cardiac indication for dual antiplatelet therapy and anticoagulation: a meta-analysis of randomized trials


Bleeding and ischemic outcomes in patients treated with dual or triple antithrombotic therapy - systematic review and meta-analysis.

Triple Antithrombotic sentence examples within Received Triple Antithrombotic



Clarithromycin/hydroxychloroquine/methylprednisolone


Clinical Use of Cangrelor After Percutaneous Coronary Intervention in Patients Requiring Mechanical Circulatory Support

Triple Antithrombotic sentence examples within Although Triple Antithrombotic



Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation


Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines-data from the POLish Atrial Fibrillation (POL-AF) Registry.

Triple Antithrombotic sentence examples within triple antithrombotic therapy



Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation – Balancing Risks and Benefits


Управление факторами риска желудочно-кишечных кровотечений на фоне антикоагулянтной терапии

Triple Antithrombotic sentence examples within triple antithrombotic treatment



Use of Direct Oral Anticoagulants After Percutaneous Coronary Intervention


Uneventful epidural catheter removal in a patient with postoperative acute coronary syndrome receiving emergency triple antithrombotic therapy: a case report.


Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation – Balancing Risks and Benefits



Управление факторами риска желудочно-кишечных кровотечений на фоне антикоагулянтной терапии



A Cautionary Tale of Triple Therapy



Comparison of clinical outcomes between multiple antithrombotic therapy versus left atrial appendage occlusion with dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation



Antithrombotic strategy in patients with atrial fibrillation and acute coronary syndrome



Long term risk and costs of bleeding in men and women treated with triple antithrombotic therapy–An observational study



Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report



Results of active remote cardiac monitoring of oncohematological patients



Fatal myopericarditis complicated with coronary vein perforation under the triple antithrombotic therapy: a case report



Antithrombotic Therapy in Patients Taking Oral Anticoagulants and Undergoing Percutaneous Coronary Intervention: Time to Be Bold and Wise.



Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention


More Triple Antithrombotic 삼중 항혈전제 sentence examples
10.1016/j.jstrokecerebrovasdis.2021.105912

Predictors of Early Stroke or Death in Patients Undergoing Transcatheter Aortic Valve Implantation.


More Triple Antithrombotic 삼중 항혈전제 sentence examples
10.1016/j.jstrokecerebrovasdis.2021.105654

Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.



One-year clinical outcome and predictors of ischemic and hemorrhagic events after percutaneous coronary intervention in elderly and very elderly patients.



Antithrombosis stewardship efforts to de-escalate inappropriate combined therapy in outpatient clinics



Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis of vitamin k antagonist a



Guidelines for mono, double and triple antithrombotic therapy



Prediction of the Individual Risk of Bleeding in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention



Management of antithrombotic therapy in patients with atrial fibrillation and acute coronary syndromes.



Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation



Bleeding Risk Profile in Patients on Oral Anticoagulation Undergoing Percutaneous Coronary Interventions: A Prospective 24 Months Cohort Study



One-year clinical outcome of patients with left ventricular thrombus after acute myocardial infarction discharged on triple or dual antithrombotic therapy



Clarithromycin/hydroxychloroquine/methylprednisolone



Comparison of Bleeding Rates between Oral Anticoagulants in Combination with Dual Antiplatelet Therapy (Triple Therapy) in a Real-World Cohort



Antithrombotic Strategies in Invasively Managed Patients with Non-ST Elevation Acute Coronary Syndromes and Non-Valvular Atrial Fibrillation in Romania.



Use of Direct Oral Anticoagulants After Percutaneous Coronary Intervention



Coronary artery thrombus resulting in ST-elevation myocardial infarction in a patient with COVID-19



Beginning the Journey to Find Optimal Antithrombotic Regimens for Korean Patients with Atrial Fibrillation after Percutaneous Coronary Intervention



Uneventful epidural catheter removal in a patient with postoperative acute coronary syndrome receiving emergency triple antithrombotic therapy: a case report.



Impact of Platelet Reactivity in ACS Patients on Clinical Outcomes with Triple Antithrombotic Therapy



An update on antithrombotic therapy in atrial fibrillation patients in long-term ambulatory setting after percutaneous coronary intervention: where do we go from here?



The interplay between atrial fibrillation and acute myocardial infarction.



The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategies.



The Prognostic Impact of Left Ventricular Thrombus Resolution after Acute Coronary Syndrome and Risk Modulation via Anti-Thrombotic Treatment Strategies



Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study.



Aspirin at 120: Retiring, recombining, or repurposing?



Antithrombotic strategies in elderly patients with atrial fibrillation revascularized with drug-eluting stents: PACO-PCI (EPIC-15) registry.



Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update



Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse events



Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation: Findings from the CONNECT AF+PCI study



Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention



Clinical Use of Cangrelor After Percutaneous Coronary Intervention in Patients Requiring Mechanical Circulatory Support



Impact of Atrial Fibrillation type in Acute Coronary Syndrome and the antithrombotic strategy



Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation



Efficacy and safety of rivaroxaban and ticagrelor in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention.



Safety and Efficacy of Triple Therapy With Ticagrelor or Prasugrel Versus Clopidogrel After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction



Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines-data from the POLish Atrial Fibrillation (POL-AF) Registry.



Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials.


More Triple Antithrombotic 삼중 항혈전제 sentence examples
10.3760/CMA.J.ISSN.1008-5734.2019.04.002

Risk of major bleeding and major adverse cardiac events in patients with acute coronary syndrome after novel oral anticoagulants therapy: a meta-analysis



Antithrombotic treatment in atrial fibrillation patients undergoing PCI: Is dual therapy the winner?



Consensus in cardiology on non-vitamin-K oral anticoagulants for patients with atrial fibrillation.



The sunset of triple antithrombotic therapy for atrial fibrillation patients



Failure of drug-coated balloon angioplasty to treat bare metal in-stent restenosis accompanied by late stent thrombosis but successful treatment of binary in-stent restenosis.



Triple Antithrombotic Therapy vs. Double Antithrombotic Therapy: One Scenario, 8 Questions, Many Conclusions



Oral Anticoagulants With Dual Antiplatelet Therapy Versus Clopidogrel in Patients After Percutaneous Coronary Intervention: A Meta-Analysis



Novel Approach of Antithrombotic Potency Amongst Patients Admitted to Hospital with Bleeding Using HEMORR2HAGES Score: A Retrospective Cohort Study.



Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials.



Short-term versus long-term triple antithrombotic therapy for patients with coronary stents and requiring oral anticoagulation: a meta-analysis of randomized clinical trials



Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice



Atrial fibrillation with percutaneous coronary intervention: Navigating the minefield of antithrombotic therapies.



From WOEST to AUGUSTUS: a review of safety and efficacy of triple versus dual antithrombotic regimens in patients with atrial fibrillation requiring percutaneous coronary intervention for acute coronary syndrome.



Omitting aspirin in PCI patients: Myth or reality?



Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting



Рациональный подход к деэскалации двойной антитромбоцитарной терапии: возможности клопидогрела



Triple or dual antithrombotic therapy post‐percutaneous coronary intervention: Which one is better?



Acute myocardial infarction in a patient positive for lupus anticoagulant: a case report



Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials.



Anticoagulation in Acute Coronary Syndrome: Review of Major Therapeutic Advances



Prediction of the Possibility of Hemorrhagic Syndrome during Combined Antiplatelet Therapy According to the Krasnodar Region Registry



Antithrombotic regimen for patients with cardiac indication for dual antiplatelet therapy and anticoagulation: a meta-analysis of randomized trials



Triple versus double antithrombotic therapy in patients with atrial fibrillation and stent implantation. A meta-analysis of randomized trials.



Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.



Consensus in cardiology on non-vitamin-K oral anticoagulants for patients with atrial fibrillation



Cardiovascular Disease in Antiphospholipid Syndrome.



Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention



[Thrombotic and hemorrhagic complications in atrial fibrillation patients, undergoing elective percutaneous coronary intervention].



Bleeding and ischemic outcomes in patients treated with dual or triple antithrombotic therapy - systematic review and meta-analysis.



Acute coronary syndrome in a patient with transient ischemic attack: challenges of antithrombotic therapy (a clinical case)



Enhanced platelet inhibition by clopidogrel and risk of bleeding in patients requiring oral anticoagulation after drug-eluting stent implantation.


Learn more from Triple Antithrombotic 삼중 항혈전제

Triple Antithrombotic 삼중 항혈전제


Triple Antithrombotic 삼중 항혈전제
Encyclopedia 백과사전